MBX Biosciences News and Activities

Presence

MBX Biosciences develops peptide medicines for endocrine and metabolic diseases. Its main products are drug candidates and research services for patients, healthcare providers, and partners in rare and chronic disease markets.

MBX Biosciences products and services overview:

Peptide therapeutics
Endocrine therapies
Metabolic treatments
Rare disease drugs
Drug development

Revenue: ~$0 million

Employees: 70

Headquarters: Carmel, United States (USA)

MBX Biosciences is one of the...

MBX Biosciences is a company listed under the stock ticker MBX (US).

Executives

View the org chart displaying its 32 main executives

Most searched biographies at MBX Biosciences

Popular executive movements at MBX Biosciences

Mark Soued has joined the company as Chief Commercial Officer (posted on May 8 2026).
Karen Basbaum has joined the company as Chief Business Offic (posted on March 10 2026).
Laurie Stelzer has joined the company as Director (posted on January 22 2026).

Click here to view some more movements at MBX Biosciences

Create your alert
to follow the executive moves at MBX Biosciences.